The Hydration Pharmaceuticals Company Limited Stock
Stocks
HPC
AU0000187957
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Australian S.E.
22:52:34 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.003000 AUD | 0.00% |
|
0.00% | -40.00% |
| Market Cap | 1.13M 995K 942K 854K 1.6M 109M 1.61M 11.25M 4.35M 55.45M 4.25M 4.16M 178M | P/E 2024 |
4.69x | P/E 2025 | -0.45x |
|---|---|---|---|---|---|
| Enterprise Value | 13.39K 11.78K 11.14K 10.1K 18.98K 1.29M 19.08K 133K 51.4K 656K 50.27K 49.18K 2.11M | EV / Sales 2024 |
0.06x | EV / Sales 2025 | 0.13x |
| Free-Float |
44.42% | Yield 2024 * |
-
| Yield 2025 | - |
| 3 months | -25.00% | ||
| 6 months | -25.00% | ||
| Current year | -40.00% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.02 |
| 3 years | 0 | | 0.04 |
| 5 years | 0 | | 0.4 |
| 10 years | 0 | | 0.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Emily Lease
PRN | Corporate Officer/Principal | - | 2026-06-14 |
Victoria Nadalin
SEC | Corporate Secretary | - | 2023-02-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Margaret Hardin
BRD | Director/Board Member | 53 | 2022-02-07 |
Nicholas Berry
CHM | Chairman | - | 2026-06-15 |
| Director/Board Member | - | 2026-06-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/4/23 | Free | Chairman | 500,000 | 0.2112% | ||
| 10/4/23 | Buy | Director | 333,333 | 0.1408% | ||
| 10/4/23 | Free | Director | 166,667 | 0.0704% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -62.50% | -92.31% | 1.13M | |
| +0.11% | +2.76% | +63.52% | +115.51% | 1,055B | |
| +0.27% | +0.73% | +51.33% | +73.10% | 654B | |
| +0.73% | +0.88% | +20.70% | +73.89% | 467B | |
| -1.36% | -0.39% | +40.20% | +41.03% | 348B | |
| +1.34% | +5.47% | +23.37% | +31.30% | 275B | |
| -0.48% | -0.06% | +13.56% | +12.36% | 258B | |
| +0.85% | +8.42% | +53.17% | +55.45% | 224B | |
| +0.85% | +1.40% | +35.78% | +101.47% | 187B | |
| -0.30% | -10.41% | -27.62% | -61.04% | 171B | |
| Average | +0.13% | +0.67% | +21.15% | +35.08% | 363.83B | |
| Weighted average by Cap. | +0.14% | +1.32% | +40.69% | +69.05% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.2M 2.82M 2.67M 2.42M 4.54M 308M 4.57M 31.85M 12.3M 157M 12.03M 11.77M 504M | 2.47M 2.17M 2.06M 1.86M 3.5M 237M 3.52M 24.56M 9.49M 121M 9.28M 9.08M 389M |
| Net income | 2.67M 2.35M 2.22M 2.01M 3.78M 256M 3.8M 26.51M 10.24M 131M 10.01M 9.8M 420M | -2.86M -2.52M -2.38M -2.16M -4.05M -275M -4.08M -28.43M -10.98M -140M -10.74M -10.51M -450M |
| Net Debt | -3.22M -2.83M -2.68M -2.43M -4.56M -309M -4.58M -31.96M -12.35M -158M -12.08M -11.81M -506M | -1.12M -984K -930K -844K -1.59M -107M -1.59M -11.12M -4.29M -54.79M -4.2M -4.11M -176M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | A$0.003000 | 0.00% | 655 |
| 26-09-23 | A$0.003000 | 0.00% | 168,000 |
| 26-09-22 | A$0.003000 | 0.00% | 49,440 |
- Stock Market
- Stocks
- HPC Stock
Select your edition
All financial news and data tailored to specific country editions
